These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25131944)

  • 1. Clinical Neuropathology image 5-2014: α-synuclein pathology in the ependyma in Parkinson's disease.
    Kovacs GG
    Clin Neuropathol; 2014; 33(5):328. PubMed ID: 25131944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon.
    Sharrad DF; de Vries E; Brookes SJ
    J Comp Neurol; 2013 Feb; 521(3):657-76. PubMed ID: 22821666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathology of α-synuclein propagation and braak hypothesis.
    McCann H; Cartwright H; Halliday GM
    Mov Disord; 2016 Feb; 31(2):152-60. PubMed ID: 26340605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies over the staging of alpha-synuclein pathology in Parkinson's disease.
    Kalaitzakis ME; Graeber MB; Gentleman SM; Pearce RK
    Acta Neuropathol; 2008 Jul; 116(1):125-8; author reply 129-31. PubMed ID: 18446352
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
    Pozo Devoto VM; Falzone TL
    Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease.
    He Y; Yu Z; Chen S
    ACS Chem Neurosci; 2019 Feb; 10(2):777-782. PubMed ID: 30183251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.
    Bobela W; Aebischer P; Schneider BL
    Biomolecules; 2015 Oct; 5(4):2675-700. PubMed ID: 26501339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral alpha-synuclein and Parkinson's disease.
    Olanow CW; Wakeman DR; Kordower JH
    Mov Disord; 2014 Jul; 29(8):963-6. PubMed ID: 25043799
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-synuclein immunohistochemistry in two cases of co-occurring idiopathic Parkinson's disease and motor neuron disease.
    Klos KJ; Josephs KA; Parisi JE; Dickson DW
    Mov Disord; 2005 Nov; 20(11):1515-20. PubMed ID: 16035099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.
    Sengupta U; Guerrero-Muñoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R
    Biol Psychiatry; 2015 Nov; 78(10):672-83. PubMed ID: 25676491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA method to detect α-synuclein oligomers in cell and animal models.
    Lassen LB; Gregersen E; Isager AK; Betzer C; Kofoed RH; Jensen PH
    PLoS One; 2018; 13(4):e0196056. PubMed ID: 29698510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models.
    Eschbach J; Danzer KM
    Neurodegener Dis; 2014; 14(1):1-17. PubMed ID: 24080741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
    Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of colonic alpha-synuclein pathology in multiple system atrophy.
    Pouclet H; Lebouvier T; Coron E; Rouaud T; Flamant M; Toulgoat F; Roy M; Vavasseur F; Bruley des Varannes S; Neunlist M; Derkinderen P
    Parkinsonism Relat Disord; 2012 Aug; 18(7):893-5. PubMed ID: 22560049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
    Shannon KM; Keshavarzian A; Dodiya HB; Jakate S; Kordower JH
    Mov Disord; 2012 May; 27(6):716-9. PubMed ID: 22550057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.